Belle V van Rosmalen1, Matthanja Bieze2, Marc G H Besselink2, Pieter Tanis2, Joanne Verheij3, Saffire S K S Phoa4, Olivier Busch2, Thomas M van Gulik5. 1. Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands. Electronic address: b.v.vanrosmalen@amc.uva.nl. 2. Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands. 3. Department of Pathology, Academic Medical Centre, Amsterdam, The Netherlands. 4. Department of Radiology, Academic Medical Centre, Amsterdam, The Netherlands. 5. Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands. Electronic address: t.m.vangulik@amc.nl.
Abstract
BACKGROUND: Benign liver tumours (e.g., hepatocellular adenoma (HCA), focal nodular hyperplasia (FNH), and haemangioma) are occasionally resected for alleged symptoms, although data on long-term outcomes is lacking. The aim of this cross-sectional study was to assess long-term outcomes of surgical intervention. METHODS: Forty patients with benign tumours (HCA 20, FNH 12, giant haemangioma 4, cysts 4) were included. Patients filled in Validated McGill Pain Questionnaires, preoperatively and after a median of 54 months after resection. Outcomes were evaluated using paired sample t-test and (M) ANOVA. RESULTS: Relief of symptoms sustained in 30/40 patients, within a follow-up of 54 (24-148) months after resection. VAS scores were reduced from 5.5 preoperatively to 1.6 postoperatively (p < 0.001). Patients with left-sided tumours had higher postoperative Pain Rating Index (PRI), compared to patients with right-sided tumours: 15.3 vs. 5.8 (p = 0.018). If patients could reconsider undergoing surgery, 34/38 would again choose resection. Discomfort at the operative scar was the most common complaint: 8/40 patients, all after open surgery, of whom 3/40 had an incisional hernia. 7/40 patients had a laparoscopic resection. CONCLUSION: Resection relieved symptoms in 30/40 patients. The operative scar was a frequent source for remaining postoperative complaints, suggesting an advantage for a laparoscopic approach when feasible.
BACKGROUND:Benign liver tumours (e.g., hepatocellular adenoma (HCA), focal nodular hyperplasia (FNH), and haemangioma) are occasionally resected for alleged symptoms, although data on long-term outcomes is lacking. The aim of this cross-sectional study was to assess long-term outcomes of surgical intervention. METHODS: Forty patients with benign tumours (HCA 20, FNH 12, giant haemangioma 4, cysts 4) were included. Patients filled in Validated McGill Pain Questionnaires, preoperatively and after a median of 54 months after resection. Outcomes were evaluated using paired sample t-test and (M) ANOVA. RESULTS: Relief of symptoms sustained in 30/40 patients, within a follow-up of 54 (24-148) months after resection. VAS scores were reduced from 5.5 preoperatively to 1.6 postoperatively (p < 0.001). Patients with left-sided tumours had higher postoperative Pain Rating Index (PRI), compared to patients with right-sided tumours: 15.3 vs. 5.8 (p = 0.018). If patients could reconsider undergoing surgery, 34/38 would again choose resection. Discomfort at the operative scar was the most common complaint: 8/40 patients, all after open surgery, of whom 3/40 had an incisional hernia. 7/40 patients had a laparoscopic resection. CONCLUSION: Resection relieved symptoms in 30/40 patients. The operative scar was a frequent source for remaining postoperative complaints, suggesting an advantage for a laparoscopic approach when feasible.
Authors: N Katkhouda; M Hurwitz; J Gugenheim; E Mavor; R J Mason; D J Waldrep; R T Rivera; M Chandra; G M Campos; S Offerman; A Trussler; P Fabiani; J Mouiel Journal: Ann Surg Date: 1999-04 Impact factor: 12.969
Authors: Frederik Jan Fabian van der Sluis; Johanna L Bosch; Türkan Terkivatan; Robert A de Man; Jan N M Ijzermans; M G Myriam Hunink Journal: Radiology Date: 2009-09 Impact factor: 11.105
Authors: Jeremiah L Deneve; Timothy M Pawlik; Steve Cunningham; Bryan Clary; Srinevas Reddy; Charles R Scoggins; Robert C G Martin; Michael D'Angelica; Charles A Staley; Michael A Choti; William R Jarnagin; Richard D Schulick; David A Kooby Journal: Ann Surg Oncol Date: 2009-01-08 Impact factor: 5.344
Authors: Diamantis I Tsilimigras; Amir A Rahnemai-Azar; Ioannis Ntanasis-Stathopoulos; Maria Gavriatopoulou; Demetrios Moris; Eleftherios Spartalis; Jordan M Cloyd; Sharon M Weber; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2018-08-14 Impact factor: 3.452
Authors: B V van Rosmalen; A J Klompenhouwer; J Jaap de Graeff; M P D Haring; V E de Meijer; L Rifai; S Dokmak; A Rawashdeh; M Abu Hilal; M C de Jong; C H C Dejong; M Doukas; R A de Man; J N M IJzermans; O M van Delden; J Verheij; T M van Gulik Journal: Br J Surg Date: 2019-07-17 Impact factor: 6.939
Authors: Margot Fodor; Florian Primavesi; Eva Braunwarth; Benno Cardini; Thomas Resch; Reto Bale; Daniel Putzer; Benjamin Henninger; Rupert Oberhuber; Manuel Maglione; Christian Margreiter; Stefan Schneeberger; Dietmar Öfner; Stefan Stättner Journal: Eur Surg Date: 2018-05-22 Impact factor: 0.953
Authors: Jan Witowski; Mateusz Rubinkiewicz; Magdalena Mizera; Michał Wysocki; Natalia Gajewska; Mateusz Sitkowski; Piotr Małczak; Piotr Major; Andrzej Budzyński; Michał Pędziwiatr Journal: Surg Endosc Date: 2018-09-10 Impact factor: 4.584